BCM
PGNX

BlueCrest Capital Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

BlueCrest Capital Management’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-17,363
Closed -$130K – 1963
2018
Q1 		$130K Buy
+17,363
New +$130K ﹤0.01% 1307